close

Mergers and Acquisitions

1 2 3 34
Number of results: 663
Date Acquired company Acquiring company Amount Related
2019-02-13 Citoxlab (France) Charles River Laboratories (USA - MA) €448 million Technology - Services
2019-01-25 Apricus Therapeutics (USA - CA) Seelos Therapeutics (USA - NY) CNS diseases - Rheumatic diseases
2019-01-25 Capua BioServices (Italy)) Olon (Italy)) CDMO - Technology - Services
2019-01-23 MAB Discovery's antibody generation unit (Germany) BioNTech (Germany) undisclosed Technologies - Services
2019-01-22 Tesaro (USA - MA) GSK (UK) $5.1 billion (£4.0 billion) Cancer - Oncology
2019-01-07 Loxo Oncology (USA - CT) Eli Lilly (USA - IN) $ 8 billion Cancer - Oncology
2019-01-06 Celgene (USa - NJ) BMS (USA - NY) $74 billion Cancer - Oncology - Cardiovascular diseases - Immunological diseases - Inflammatory diseases
2019-01-04 Oncotelix Mabvax Cancer - Digestive diseases
2018-12-31 Tonipharm (France) Recordati (Italy) OTC
2018-12-21 Endocyte (USA - IN) Novartis (Switzerland) $ 2.1 billion Cancer - Oncology
2018-12-20 Cellforcure (France) Novartis (Switzerland) CDMO -
2018-12-06 Recordati (Italy) CVC Fund VII €3.03 billion
2018-11-02 Syntimmune (USA - MA) Alexion Pharmaceuticals (USA - CT) up to $1.2 billion
2018-10-26 Shire (UK - USA) Takeda Pharmaceutical (Japan) $ 62 billion Gastroinstestinal diseases - Neurosciences - Rare diseases - Genetic diseases - Immunological diseases
2018-10-09 Vector Neurosciences (UK) MeiraGTx (USA - NY) Neurodegenerative diseases - CNS diseases
2018-10-04 PaxVax (USA - CA) Emergent BioSolutions (USA - MD) $270 million Infectious diseases
2018-10-01 Sanofi’s inhalation contract manufacturing business Recipharm (Sweden) undisclosed Technology - Services
2018-09-26 Syntimmune (USA - MA) Alexion Pharmaceuticals (USA -MA) up to $1.2 billion Autoimmune diseases
2018-09-20 Celenex Amicus Therapeutics (USA - NJ) $100 million in an upfront cash payment and up to $15 million in development milestones and $262 million in BLA/MAA submission and approval milestones Gene Therapy - Rare diseases - CNS diseases
2018-09-14 Bonti (USA - CA) Allergan (Ireland) $195 million and additional potential commercial milestone payments, subject to certain adjustments and other customary closing conditions aesthetic medicine